Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Pancera

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Virology|January 22, 2005
Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavageMarie Pancera, Richard Wyatt
Immunological Reviews|January 31, 2017
Germline-targeting immunogensLeonidas Stamatatos, Marie Pancera, Andrew T McGuire
Current Opinion in HIV and AIDS|April 20, 2017
How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine designMarie Pancera, Anita Changela, Peter D Kwong
Biorxiv : the Preprint Server for Biology|June 12, 2025
Structural basis for antibody cross-neutralization of dengue and Zika virusesNicholas K Hurlburt, Jay Lubow, Leslie Goo, et al.
Communications Biology|March 11, 2026
Structural basis for antibody cross-neutralization of Dengue and Zika virusesNicholas K Hurlburt, Jay Lubow, Leslie Goo, et al.
Analytical Biochemistry|May 2, 2006
A biosensor-based approach toward purification and crystallization of G protein-coupled receptorsIva Navratilova, Marie Pancera, Richard T Wyatt, et al.
Virology|November 6, 2004
Factors limiting the immunogenicity of HIV-1 gp120 envelope glycoproteinsChristoph Grundner, Marie Pancera, Joung-Mo Kang, et al.
Journal of Virology|February 13, 2009
Identification of a human immunodeficiency virus type 1 envelope glycoprotein variant resistant to cold inactivationAemro Kassa, Andrés Finzi, Marie Pancera, et al.
Journal of Virology|November 8, 2024
Structural analysis of a non-pathogenic hare calicivirus capsid bound to a histo-blood group antigen co-factorGrant S Hansman, Todd Reese, Marie Pancera, et al.
Nature Communications|February 13, 2023
Cross-protective antibodies against common endemic respiratory virusesMadelyn Cabán, Justas V Rodarte, Madeleine Bibby, et al.
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Virology|January 22, 2005
Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavageMarie Pancera, Richard Wyatt
Immunological Reviews|January 31, 2017
Germline-targeting immunogensLeonidas Stamatatos, Marie Pancera, Andrew T McGuire
Current Opinion in HIV and AIDS|April 20, 2017
How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine designMarie Pancera, Anita Changela, Peter D Kwong
Biorxiv : the Preprint Server for Biology|June 12, 2025
Structural basis for antibody cross-neutralization of dengue and Zika virusesNicholas K Hurlburt, Jay Lubow, Leslie Goo, et al.
Communications Biology|March 11, 2026
Structural basis for antibody cross-neutralization of Dengue and Zika virusesNicholas K Hurlburt, Jay Lubow, Leslie Goo, et al.
Analytical Biochemistry|May 2, 2006
A biosensor-based approach toward purification and crystallization of G protein-coupled receptorsIva Navratilova, Marie Pancera, Richard T Wyatt, et al.
Virology|November 6, 2004
Factors limiting the immunogenicity of HIV-1 gp120 envelope glycoproteinsChristoph Grundner, Marie Pancera, Joung-Mo Kang, et al.
Journal of Virology|February 13, 2009
Identification of a human immunodeficiency virus type 1 envelope glycoprotein variant resistant to cold inactivationAemro Kassa, Andrés Finzi, Marie Pancera, et al.
Journal of Virology|November 8, 2024
Structural analysis of a non-pathogenic hare calicivirus capsid bound to a histo-blood group antigen co-factorGrant S Hansman, Todd Reese, Marie Pancera, et al.
Nature Communications|February 13, 2023
Cross-protective antibodies against common endemic respiratory virusesMadelyn Cabán, Justas V Rodarte, Madeleine Bibby, et al.
Pageof 12